Impact of Dairy Integration Into Canadian Food Guide on Gut Health

NCT07257913 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-12-02

No results posted yet for this study

Summary

The primary objective is to investigate the impact of milk, fermented milk, and soy beverages, incorporated in a diet reflecting adherence to Canadian food guide recommendations on food choices on gut microbiota in middle-aged adults (45-65 years) with abdominal obesity and slightly deteriorated lipids and/or glucose profile. The study aims to discern whether the integration of soy beverages (control), milk, and fermented milk within the CFG diet contributes to distinct gut outcomes and alterations in gut health. We hypothesized that milk and fermented milk will further promote beneficial changes in gut health parameters including gut microbiota composition, trans-epithelial permeability, and inflammation, relative to soy beverages.

Conditions

  • Gut Epithelial Permeability
  • Gut Microbiota Composition and Diversity
  • Gut and Circulating Inflammatory Markers
  • Milk and Digestion

Interventions

OTHER

Milk

Consumption of 1 cup milk 3 times per day during 9 days alongside CFG diet

OTHER

Fermented milk

Consumption of fermented milk 3 times per day during 9 days alongside CFG diet

OTHER

Soy beverage

Consumption of a soy beverage 3 times per day during 9 days alongside CFG diet

Sponsors & Collaborators

  • Laval University

    lead OTHER

Principal Investigators

  • Alain Veilleux, PhD · Laval University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-06
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07257913 on ClinicalTrials.gov